Alerts will be sent to your verified email
Verify Email
AAREYDRUGS
|
Aarey Drugs & Pharma
|
Amwill Health Care
|
IndoAmerican Advance
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
5.07 % | 101.41 % | -12.16 % |
|
5yr average Equity Multiplier
|
2.28 | 0.14 | 1.07 |
|
5yr Average Asset Turnover Ratio
|
1.56 | 2.8 | 0.15 |
|
5yr Avg Net Profit Margin
|
1.44 % | 10.66 % | -36.65 % |
|
Price to Book
|
1.22 | 0.0 | n/a |
|
P/E
|
29.17 | 13.62 | n/a |
|
5yr Avg Cash Conversion Cycle
|
77.34 Days | -8.95 Days | 0.0 |
|
Inventory Days
|
20.31 Days | 31.9 Days | 0.0 |
|
Days Receivable
|
172.65 Days | 58.92 Days | 0.0 |
|
Days Payable
|
98.9 Days | 155.72 Days | 167.71 Days |
|
5yr Average Interest Coverage Ratio
|
4.14 | 0.0 | -55.68 |
|
5yr Avg ROCE
|
8.93 % | 124.16 % | -12.15 % |
|
5yr Avg Operating Profit Margin
|
1.54 % | 14.93 % | -72.03 % |
|
5 yr average Debt to Equity
|
0.21 | 0.0 | 0.0 |
|
5yr CAGR Net Profit
|
-4.17 % | n/a | n/a |
|
5yr Average Return on Assets
|
2.26 % | 29.83 % | -11.02 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
44.8 % | 70.65 % | 0.97 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-3.26 % | 0.0 | -17.4 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Aarey Drugs & Pharma
|
Amwill Health Care
|
IndoAmerican Advance
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|